Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PGD | P52209 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL645759 | 1.00 | PDE4A (0.39) | PDE4ATSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL570718 | 0.84 | TSHR (0.33) | TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL5458333 | 0.84 | TSHR (0.33) | PDE4ATSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL7148889 | 0.84 | TSHR (0.33) | TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL23923262 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL1037497 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL1950299 | 0.80 | PDE4A (0.36) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL6258700 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL10885691 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 | |
| SCHEMBL23925241 | 0.79 | PDE4A (0.39) | PDE4ATSHRCYP2C9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797942-B1 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | GALECTIN THERAPEUTICS INC (US) | 2018-10-31 | — | — | EP | claimed |
| EP-2906227-B1 | GALACTOSE-PRONGED CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS | GALECTIN THERAPEUTICS INC (US) | 2018-10-03 | — | — | EP | claimed |
| WO-2006104503-A1 | STRESS TOLERANT TRANSGENIC PLANTS OVER-EXPRESSING GENES OF ASCORBIC ACID SYNTHESIS-CELL WALL | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2006-10-05 | — | — | WO | claimed |
| EP-4044822-B1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | NESTLE SA (CH) | 2024-05-15 | — | — | EP | disclosed |
| US-20240099326-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2024-03-28 | — | — | US | disclosed |
| CN-116670296-A | Method for producing sugar products and fermentation products | 维尔萨利斯股份公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-107406862-B | Process for enzymatic hydrolysis of lignocellulosic material and fermentation of sugars | 帝斯曼知识产权资产管理有限公司 | 2022-08-09 | — | — | CN | disclosed |
| US-20220225632-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-07-21 | — | — | US | disclosed |
| US-20220217988-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | NESTLE SA (CH) | 2022-07-14 | — | — | US | disclosed |
| US-11369122-B2 | Chocolate products, ingredients, processes and uses | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-06-28 | — | — | US | disclosed |
| CN-107075533-B | Process for enzymatic hydrolysis of lignocellulosic material and fermentation of sugars | 帝斯曼知识产权资产管理有限公司 | 2021-11-02 | — | — | CN | disclosed |
| US-6177256-B1 | VACCINE DIRECTED AGAINST TUMOR CELLS EXPRESSING MUCIN; CONJUGATE OF HUMAN MUCIN POLYPEPTIDE OR VARIABLE NUMBER OF TANDEM REPEATS AND OXIDIZED MANNAN IN A PHARMACEUTICALLY ACCEPTABLE CARRIER; ANTICANCER AGENTS AGAINST BREAST CANCER | AUSTIN RESEARCH INSTITUTE (AU) | 2001-01-23 | — | — | US | disclosed |
| EP-1027063-A1 | MANNOSE RECEPTOR BEARING CELL LINE AND ANTIGEN COMPOSITION | THE AUSTIN RESEARCH INSTITUTE (AU) | 2000-08-16 | — | — | EP | disclosed |
| US-5989552-A | Antigen carbohydrate compounds and their use in immunotherapy | AUSTIN RESEARCH INSTITUTE (AU) | 1999-11-23 | — | — | US | disclosed |
| US-5985593-A | DETERMINATION OF MICROORGANISM CONTAINING MYCOLIC ACID IN EXTERIOR MEMBRANE; ENZYME LYSIS | INTEGRATED RESEARCH TECHNOLOGY, L.L.C. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999016455-A1 | MANNOSE RECEPTOR BEARING CELL LINE AND ANTIGEN COMPOSITION | THE AUSTIN RESEARCH INSTITUTE (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1995018145-A1 | CONJUGATES OF HUMAN MUCIN AND A CARBOHYDRATE POLYMER AND THEIR USE IN CANCER TREATMENT | ILEXUS PTY LTD (AU) | 1995-07-06 | — | — | WO | disclosed |
| EP-0659768-A2 | Antigen-carbohydrate conjugates and their use in immunotherapy | ILEXUS PTY LTD (AU) | 1995-06-28 | — | — | EP | disclosed |
| US-4617276-A | SUBTRACTING THE DETERMINED AMOUNTS OF PROTEIN, LIPID, ASH AND NEUTRAL DETERGENT FIBER | AGWAY INC. (US) | 1986-10-14 | — | — | US | disclosed |
| US-4615891-A | Method of formulating dairy cow rations based on carbohydrate regulation | AGWAY INC. (US) | 1986-10-07 | — | — | US | disclosed |